These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25117705)

  • 1. YAPping about differentiation therapy in muscle cancer.
    Svalina MN; Keller C
    Cancer Cell; 2014 Aug; 26(2):154-5. PubMed ID: 25117705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.
    Tremblay AM; Missiaglia E; Galli GG; Hettmer S; Urcia R; Carrara M; Judson RN; Thway K; Nadal G; Selfe JL; Murray G; Calogero RA; De Bari C; Zammit PS; Delorenzi M; Wagers AJ; Shipley J; Wackerhage H; Camargo FD
    Cancer Cell; 2014 Aug; 26(2):273-87. PubMed ID: 25087979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma.
    Rivera-Reyes A; Ye S; E Marino G; Egolf S; E Ciotti G; Chor S; Liu Y; Posimo JM; Park PMC; Pak K; Babichev Y; Sostre-Colón J; Tameire F; Leli NM; Koumenis C; C Brady D; Mancuso A; Weber K; Gladdy R; Qi J; Eisinger-Mathason TSK
    Cell Death Dis; 2018 Oct; 9(11):1108. PubMed ID: 30382078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.
    Slemmons KK; Yeung C; Baumgart JT; Juarez JOM; McCalla A; Helman LJ
    Cancer Res; 2020 Jul; 80(14):3046-3056. PubMed ID: 32354737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
    Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
    Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
    Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
    Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression.
    Melhuish TA; Kowalczyk I; Manukyan A; Zhang Y; Shah A; Abounader R; Wotton D
    Biochim Biophys Acta Gene Regul Mech; 2018 Nov; 1861(11):983-995. PubMed ID: 30312684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances in the development of therapies for neuromuscular disorders based on myostatin signalling, 3rd International Institute of Myology Workshop, Paris, September 12th, 2008.
    Dumonceaux J; Amthor H
    Neuromuscul Disord; 2009 Nov; 19(11):797-9. PubMed ID: 19783146
    [No Abstract]   [Full Text] [Related]  

  • 10. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
    Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
    Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
    Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
    Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair.
    Deng Y; Wu A; Li P; Li G; Qin L; Song H; Mak KK
    Cell Rep; 2016 Mar; 14(9):2224-2237. PubMed ID: 26923596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts.
    Piersma B; de Rond S; Werker PM; Boo S; Hinz B; van Beuge MM; Bank RA
    Am J Pathol; 2015 Dec; 185(12):3326-37. PubMed ID: 26458763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
    Li YW; Guo J; Shen H; Li J; Yang N; Frangou C; Wilson KE; Zhang Y; Mussell AL; Sudol M; Farooq A; Qu J; Zhang J
    Cell Cycle; 2016 Sep; 15(18):2497-505. PubMed ID: 27428284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover.
    Hong X; Nguyen HT; Chen Q; Zhang R; Hagman Z; Voorhoeve PM; Cohen SM
    EMBO J; 2014 Nov; 33(21):2447-57. PubMed ID: 25180228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo/YAP, β-catenin, and the cancer cell: a "ménage à trois" in hepatoblastoma.
    Sylvester KG; Colnot S
    Gastroenterology; 2014 Sep; 147(3):562-5. PubMed ID: 25072176
    [No Abstract]   [Full Text] [Related]  

  • 18. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
    Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
    Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
    Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS
    Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RAS and YAP1 dance, who is leading?
    Corbo V; Ponz-Sarvise M; Tuveson DA
    EMBO J; 2014 Nov; 33(21):2437-8. PubMed ID: 25257311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.